Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Leidos Holdings, Inc.    LDOS

LEIDOS HOLDINGS, INC.

(LDOS)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Leidos : Ravens And Leidos Host Prescription Drug Take Back

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/10/2019 | 03:06pm EDT

BALTIMORE, Oct. 10, 2019 /PRNewswire/ -- In support of the DEA's 'National Prescription Drug Take Back Day,' the 70,000 fans attending this Sunday's (Oct. 13) Baltimore Ravens game against the Cincinnati Bengals can bring unused prescription drugs and dispose of them on RavensWalk (located on the north side, Oriole Park side, of M&T Bank Stadium). Additionally, drug disposal packets will be distributed for Ravens fans to safely dispose of unused prescription drugs in the future.

The take back day is an event within the 'Tackling Opioid Addiction' campaign launched by the Ravens and Leidos this season. Both are working alongside Maryland's Office of the Attorney General and the Drug Enforcement Agency for this Sunday's event, which will take place from 10 a.m. to 1 p.m.

Disposal is free and anonymous. Maryland Attorney General Brian E. Frosh explained: 'With opioid use and abuse at epidemic levels across the country, consumers should dispose of expired, unused or unwanted medicines to reduce accidental or intentional overdose or illegal abuse.'

The DEA will safely dispose of all prescription drugs brought to the game. Those items that will NOT be accepted are:

  • Liquids
  • Needles
  • Asthma Inhalers
  • Mercury Thermometers
  • Iodine-containing Medicines

Fans should bring only those drugs that are prescribed/controlled substances.

'This is an important and worthwhile effort that pairs private companies like ours and Leidos with government agencies to address a real-life issue, the abuse of opioid medicines in our area and across the country,' Ravens president Dick Cass said.

'Disposing of prescription drugs safely during National Take Back Days or at DEA local collection sites is a simple activity that reduces the supply of unneeded opioids in our medicine cabinets,' Leidos Chairman and CEO Roger Krone said.

About Baltimore Ravens
Entering their 24th year of existence, the Baltimore Ravens are just one of four NFL franchises to win multiple Super Bowls since the turn of the century. Under head coach John Harbaugh, who arrived in 2008, Baltimore has posted the NFL's fifth-most total victories (117), won the league's second-most playoff games (10), advanced to an impressive three AFC Championship contests, and in 2012, captured the World Championship in Super Bowl XLVII. The Ravens, who also won Super Bowl XXXV during the 2000 campaign, have made the playoffs in eight of the past 13 seasons - producing four AFC North Division titles during this time (2006, 2011, 2012 & 2018).

About Leidos
Leidos is a Fortune 500® information technology, engineering, and science solutions and services leader working to solve the world's toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company's 33,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $10.19 billion for the fiscal year ended December 28, 2018. For more information, visit www.Leidos.com.

Baltimore Ravens Contact:
Kevin Rochlitz
(410) 701-4122
Kevin.rochlitz@ravens.nfl.net

Leidos Contacts:
Melissa Koskovich
(571) 526-6011
Koskovichm@Leidos.com

Suzzanna Martinez
(303) 299-5343
suzzanna.m.martinez@leidos.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/ravens-and-leidos-host-prescription-drug-take-back-300936758.html

SOURCE Leidos

Disclaimer

Leidos Holdings Inc. published this content on 10 October 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 October 2019 19:05:07 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LEIDOS HOLDINGS, INC.
10/17LEIDOS : to Provide Nuclear Test Ban Treaty Technical Support Services
PR
10/14LEIDOS : Awarded TSA Screening Equipment Contract
PR
10/10LEIDOS : to Provide National Institutes of Health Software Development Support S..
PR
10/10LEIDOS : Ravens And Leidos Host Prescription Drug Take Back
PU
10/08LEIDOS : to Showcase Army Readiness and Modernization Solutions at AUSA 2019
PR
10/03LEIDOS : Joins the Scaled Agile Partner Network as a Gold Partner
PR
10/01LEIDOS : Home Office appoints Leidos UK to deliver transformation of its biometr..
PU
09/26LEIDOS SCHEDULES THIRD QUARTER 2019 : 00am (et)
PR
09/19LEIDOS : rsquo; Sea Hunter makes history again
PU
09/19LEIDOS : ' Sea Hunter Makes History Again
PR
More news
Financials (USD)
Sales 2019 10 834 M
EBIT 2019 902 M
Net income 2019 625 M
Debt 2019 2 477 M
Yield 2019 1,63%
P/E ratio 2019 19,0x
P/E ratio 2020 18,0x
EV / Sales2019 1,31x
EV / Sales2020 1,25x
Capitalization 11 751 M
Chart LEIDOS HOLDINGS, INC.
Duration : Period :
Leidos Holdings, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LEIDOS HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 90,69  $
Last Close Price 81,62  $
Spread / Highest target 21,3%
Spread / Average Target 11,1%
Spread / Lowest Target -1,98%
EPS Revisions
Managers
NameTitle
Roger A. Krone Chairman & Chief Executive Officer
James Corbett Reagan Chief Financial Officer & Executive VP
Donald Kosiak Chief Medical Officer
Steve Hull Chief Information Officer & Senior Vice President
James F. Carlini Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
LEIDOS HOLDINGS, INC.54.99%11 751
INTERNATIONAL BUSINESS MACHINES CORPORATION18.11%118 938
ACCENTURE31.93%118 534
TATA CONSULTANCY SERVICES7.28%107 189
AUTOMATIC DATA PROCESSING24.95%71 053
VMWARE, INC.10.90%62 145